ReShape Lifesciences™ to Present at Oppenheimer Fall Healthcare Life Sciences and Med Tech Summit on September 20, 2021
The Company’s presentation details include:
Date:
Time:
Location: Webcast Link
An audio webcast of ReShape’s presentation will be available on the investor relations section of the Company’s website, ir.reshapelifesciences.com. Replays of the webcast will be available for 90 days after the date of the presentation.
ReShape’s management team will also be available for one-on-one meetings throughout the summit. For more information about the conference or to schedule a one-on-one meeting with management, please contact your Oppenheimer representative or
ABOUT
ReShape Lifesciences™ is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the
CONTACTS
ReShape Lifesciences Investor Contact:
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com
Investor Contact:
Assistant Vice President
646-536-7019
dboateng@theruthgroup.com
Source: ReShape Lifesciences Inc